Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
491,793,998
Market Cap (USD)
355,370,343
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63 %
Free-Float capitalization (CAD)
278,489,579
Free-Float capitalization (USD)
201,236,569
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 355M | |
| -0.25% | -0.96% | +45.25% | +102.76% | 68.52B | |
| -1.09% | -4.97% | +31.10% | +76.56% | 62.88B | |
| -1.18% | +0.51% | -13.53% | +384.69% | 28.13B | |
| -2.74% | -3.53% | +26.13% | +13.50% | 25.56B | |
| -1.76% | -7.14% | -5.57% | -19.75% | 24.65B | |
| -2.39% | -4.23% | +18.42% | -20.95% | 19.81B | |
| -1.86% | +1.15% | +205.44% | +353.89% | 17.69B | |
| -1.37% | -3.77% | -9.38% | +528.34% | 14.66B | |
| -1.54% | -1.88% | +50.03% | +159.75% | 14.45B | |
| Average | -1.58% | -1.33% | +38.65% | +175.42% | 27.67B | |
| Weighted average by Cap. | -1.28% | -1.41% | +35.43% | +139.07% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
